122 related articles for article (PubMed ID: 3906477)
1. [Prognostic factors of ovarian cancer].
Meerpohl HG
Onkologie; 1985 Oct; 8(5):296-304. PubMed ID: 3906477
[TBL] [Abstract][Full Text] [Related]
2. Influence of surgery and postoperative therapy and tumor characteristics on patient prognosis in advanced ovarian carcinomas.
von Georgi R; Franke FE; Münstedt K
Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):189-96. PubMed ID: 14597250
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma.
Sevelda P; Denison U; Schemper M; Spona J; Vavra N; Salzer H
Br J Obstet Gynaecol; 1990 Aug; 97(8):706-12. PubMed ID: 2400748
[TBL] [Abstract][Full Text] [Related]
4. [Biology of ovarian carcinoma and the hope of individualised therapy].
Pfeiderer A
Onkologie; 1984 May; 7 Suppl 2():82-8. PubMed ID: 6087232
[TBL] [Abstract][Full Text] [Related]
5. [The second-look operation in advanced ovarian cancer--experiences since the introduction of cisplatin combination chemotherapy].
Kaufmann M; Hanke J; Schmid H; Kühn W; Kubli F
Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):581-7. PubMed ID: 3770408
[TBL] [Abstract][Full Text] [Related]
6. Brenner and transitional cell tumours of the ovary. Report of three cases.
Rantanen V; Grénman S; Kiilholma P; Salmi T; Klemi PJ
Ann Chir Gynaecol Suppl; 1994; 208():28-32. PubMed ID: 8092766
[TBL] [Abstract][Full Text] [Related]
7. [Steroid hormone receptors in ovarian carcinomas and their clinical significance].
Geyer H; Teufel G; de Gregorio G; Pfleiderer A
Onkologie; 1984 May; 7 Suppl 2():44-52. PubMed ID: 6379538
[TBL] [Abstract][Full Text] [Related]
8. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
von Minckwitz G; Kaufmann M
Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
[No Abstract] [Full Text] [Related]
9. [Morphology and growth behavior of ovarian tumors. Studies using DNA cytophotometry, immunohistology and tissue culture].
Dietel M; Arps H
Onkologie; 1985 Oct; 8(5):278-80, 285. PubMed ID: 3906475
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
11. [Clinical aspects and pathology of granulosa cell tumors. A single case report].
Wessel J; Minguillon C
Zentralbl Gynakol; 1992; 114(3):136-40. PubMed ID: 1595308
[TBL] [Abstract][Full Text] [Related]
12. [Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
Sevelda P
Wien Klin Wochenschr Suppl; 1990; 183():3-29. PubMed ID: 2145702
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the rupture of the capsule in stage I epithelial ovarian carcinoma.
Sevelda P; Dittrich C; Salzer H
Gynecol Oncol; 1989 Dec; 35(3):321-2. PubMed ID: 2599467
[TBL] [Abstract][Full Text] [Related]
14. [Possibilities and limits of the study of tumor markers in the after-care of patients with ovarian cancer].
Kreienberg R
Gynakologe; 1986 Sep; 19(3):178-85. PubMed ID: 3770529
[No Abstract] [Full Text] [Related]
15. [Prognostic factors of common epithelial ovarian cancer treated by surgery and cisplatin based combination chemotherapy].
Sasaki H; Ochiai K; Terashima Y; Mochizuki S; Soda T; Nishimura H; Yakushiji M; Hirabayashi M
Gan No Rinsho; 1989 Oct; 35(13):1615-20. PubMed ID: 2585733
[TBL] [Abstract][Full Text] [Related]
16. [Steroid receptor status as prognostic factor in ovarian cancer].
Schieder K; Biegelmayer C; Kölbl H; Breitenecker G
Gynakol Rundsch; 1990; 30 Suppl 1():65-7. PubMed ID: 2079302
[No Abstract] [Full Text] [Related]
17. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
Rose PG; Reale FR; Longcope C; Hunter RE
Obstet Gynecol; 1990 Aug; 76(2):258-63. PubMed ID: 2371031
[TBL] [Abstract][Full Text] [Related]
18. The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study.
Hofstetter G; Concin N; Braicu I; Chekerov R; Sehouli J; Cadron I; Van Gorp T; Trillsch F; Mahner S; Ulmer H; Grimm C; Castillo-Tong DC; Zeillinger R; Zeimet AG; Vergote I
Gynecol Oncol; 2013 Oct; 131(1):15-20. PubMed ID: 23877013
[TBL] [Abstract][Full Text] [Related]
19. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
Schwartz PE; MacLusky N; Merino MJ; Livolsi VA; Kohorn EI; Eisenfeld A
Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
[TBL] [Abstract][Full Text] [Related]
20. The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer.
Dean CJ; Allan S; Eccles S; McFarlane C; Styles J; Valeri M; Sandle J; Bakir A; Sacks N
Year Immunol; 1993; 7():182-92. PubMed ID: 8103950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
